Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

155 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 98% dehydrated alcohol Ethanol 4件: D00068, D02798, D04855, D06542 💬 - - 1件: 298 💬
2 A04ad10 - - - - 1件: 298 💬
3 Acetate Acetate - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
4 Acetyl-l-carnitine Acetylcarnitine 3件: D02030, D02176, D04713 💬 - - 1件: 298 💬
5 Acetyl-l-carnitine 1000mg 2x per day for 3 months Acetylcarnitine 3件: D02030, D02176, D04713 💬 - - 1件: 298 💬
6 Acetylcysteine Acetylcysteine 1件: D00221 💬 - - 16件:  6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬
7 Alanine Alanine 1件: D00012 💬 - - 4件:  6 , 13, 298, 299 💬
8 Alcohol Ethanol 4件: D00068, D02798, D04855, D06542 💬 - - 4件: 13, 58, 279, 298 💬
9 Alpha 1-antitrypsin Alpha-1-proteinase inhibitor - - - 2件: 231, 298 💬
10 Amino acids Amino acids - - - 3件: 70, 240, 298 💬
11 Amlodipine Amlodipine 3件: D00615, D02914, D07450 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 51, 67, 298 💬
12 Amlodipine (drug) Amlodipine 3件: D00615, D02914, D07450 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 298 💬
13 Analgesics - - - - 1件: 298 💬
14 Antioxidant plus pregabalin Pregabalin 1件: D02716 💬 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 1件: 298 💬
15 Antioxidants - - - - 3件: 90, 298, 310 💬
16 Antox - - - - 1件: 298 💬
17 Antox (vers) 1.2 - - - - 1件: 298 💬
18 Antox (vers.)1.2 - - - - 1件: 298 💬
19 Antox version 1.2 - - - - 1件: 298 💬
20 Ascorbic acid Ascorbic acid 1件: D00018 💬 - - 4件: 10, 97, 206, 298 💬
21 Autologous mesenchymal stromal cell - - - - 2件: 96, 298 💬
22 Behavioral: smoking and alcohol assumption Ethanol 4件: D00068, D02798, D04855, D06542 💬 - - 1件: 298 💬
23 Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala) Alanine 1件: D00012 💬 - - 1件: 298 💬
24 Bupivacaine Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬
25 Bupivicaine alone - - - - 1件: 298 💬
26 Calcium Calcium - - - 27件:  6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
27 Calcium, dietary Calcium - - - 1件: 298 💬
28 Carbon Activated charcoal 1件: D03251 💬 - - 9件:  6 , 46, 50, 51, 85, 86, 96, 97, 298 💬
29 Carbon monoxide Activated charcoal 2件: D03251, D09706 💬 - - 3件: 85, 86, 298 💬
30 Carnitine Levocarnitine 3件: D02030, D02176, D04713 💬 - - 8件:  5 , 13, 58, 96, 97, 265, 298, 316 💬
31 Cholecalciferol Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
32 Creon - - - - 2件: 298, 299 💬
33 Creon 10000 - - - - 2件: 298, 299 💬
34 Creon 25000 - - - - 2件: 298, 299 💬
35 Creon36™ - - - - 1件: 298 💬
36 Device: mayo interactive breath hold monitor Methamidophos - - - 2件: 298, 300 💬
37 Diagnostic test: genetic sequencing - - - - 1件: 298 💬
38 Diagnostic test: hemoglobin a1c Hemoglobin - - - 1件: 298 💬
39 Diagnostic test: mixed meal tolerance test - - - - 1件: 298 💬
40 Diagnostic test: other exploratory blood biomarkers - - - - 1件: 298 💬
41 Diazepam Diazepam 1件: D00293 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 3件: 46, 155, 298 💬
42 Dronabinol Dronabinol 1件: D00306 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 5件:  2 , 13, 46, 271, 298 💬
43 Ensure surgical - - - - 1件: 298 💬
44 Ercp with bupivacaine infusion Bupivacaine 2件: D01450, D07552 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 298 💬
45 Esomeprazole Esomeprazole 4件: D01984, D04056, D07917, D09339 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 6件: 13, 46, 86, 98, 298, 299 💬
46 Etanercept Etanercept 1件: D00742 💬 2件: LTA, TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 14件: 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
47 Eur-1008 (apt-1008) high dose - - - - 1件: 298 💬
48 Eur-1008 (apt-1008) low dose - - - - 1件: 298 💬
49 Eur-1066-a - - - - 1件: 298 💬
50 Eur-1066-b - - - - 1件: 298 💬
51 Eus procedure with drug injection - - - - 1件: 298 💬
52 Fluimucil - - - - 4件: 85, 94, 193, 298 💬
53 Fluimucil*20cpr eff 600mg - - - - 2件: 94, 298 💬
54 Gabapentin Gabapentin 1件: D00332 💬 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 5件:  6 , 13, 19, 70, 298 💬
55 Gabapentin prescriptions Gabapentin 1件: D00332 💬 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 1件: 298 💬
56 Gold Gold - - - 38件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
57 Helopanflat mono® - - - - 1件: 298 💬
58 Hemoglobin Hemoglobin - - - 1件: 298 💬
59 Human secretin Secretin human - - - 1件: 298 💬
60 Hydroxychloroquine Hydroxychloroquine 1件: D08050 💬 - - 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬
61 Indomethacin Indomethacin 3件: D00141, D01565, D02110 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 3件: 225, 271, 298 💬
62 Intra plexus triamcinolone and bupivicaine injection Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 298 💬
63 Kreon 25000 - - - - 2件: 298, 299 💬
64 L-carnitine Levocarnitine 3件: D02030, D02176, D04713 💬 - - 6件: 13, 96, 97, 265, 298, 316 💬
65 Lannacher - - - - 1件: 298 💬
66 Lanreotide Lanreotide 1件: D04666 💬 - - 4件: 67, 73, 85, 298 💬
67 Lanreotide acetate Acetate 1件: D04666 💬 - - 4件: 67, 73, 85, 298 💬
68 Lipase - - - - 2件: 298, 299 💬
69 Liprotamase - - - - 2件: 298, 299 💬
70 Lyrica - - - - 1件: 298 💬
71 Lyrica® - - - - 1件: 298 💬
72 Magnesiocard 2.5mmol - - - - 1件: 298 💬
73 Magnesium Magnesium - - - 16件:  6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
74 Magnesium aspartate Magnesium 1件: D02026 💬 - - 1件: 298 💬
75 Magnesium aspartate hydrochloride Magnesium 1件: D02026 💬 - - 1件: 298 💬
76 Methionine Methionine 2件: D00019, D04983 💬 - - 7件: 34, 75, 84, 93, 229, 298, 300 💬
77 Mezym f - - - - 1件: 298 💬
78 Midazolam Midazolam 3件: D00550, D00696, D05028 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 11件:  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 298 💬
79 Monitor Methamidophos - - - 18件:  2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬
80 Ms1819 - - - - 2件: 298, 299 💬
81 Ms1819-sd MS-1819 - - - 2件: 298, 299 💬
82 Multienzymes (lipase, protease etc.) - - - - 2件: 298, 299 💬
83 Namisol - - - - 2件: 13, 298 💬
84 Nexium (esomeprazole magnesium) Esomeprazole 4件: D01984, D04056, D07917, D09339 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件: 298 💬
85 Ni-03 - - - - 1件: 298 💬
86 Omeprazole Omeprazole 4件: D00455, D01207, D05259, D05261 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 16件:  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
87 Other: carbon monoxide-bubbled mediums Activated charcoal 2件: D03251, D09706 💬 - - 1件: 298 💬
88 Other: eus procedure - - - - 1件: 298 💬
89 Other: laboratory biomarker analysis - - - - 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬
90 Other: low-intensity exercise therapy - - - - 1件: 298 💬
91 Other: no enzyme therapy - - - - 1件: 298 💬
92 Other: nutrition counseling - - - - 1件: 298 💬
93 Other: quality-of-life assessment - - - - 5件: 34, 36, 51, 96, 298 💬
94 Other: questionnaire administration - - - - 4件: 16, 34, 51, 298 💬
95 Oxycodone Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 7件:  6 , 13, 46, 70, 226, 231, 298 💬
96 Oxycodone depot ”sandoz”, depot tablets Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 298 💬
97 Oxycodone hydrochloride Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 4件:  6 , 70, 226, 298 💬
98 Oxycodonhydrochlorid ”lannacher”, depot tablets - - - - 1件: 298 💬
99 Oxynorm - - - - 1件: 298 💬
100 Pancreatic enzymes - - - - 1件: 298 💬
101 Pancreatin Pancrelipase 1件: D05349 💬 - - 2件: 298, 299 💬
102 Pancrelipase Pancrelipase 1件: D05349 💬 - - 2件: 298, 299 💬
103 Pancrelipase delayed release capsule Pancrelipase 1件: D05349 💬 - - 2件: 298, 299 💬
104 Pancrelipase/pancreas powder Pancrelipase 1件: D05349 💬 - - 2件: 298, 299 💬
105 Panzytrat - - - - 1件: 298 💬
106 Panzytrat 25.000 - - - - 1件: 298 💬
107 Panzytrat 25.000 fip-e units of lipase - - - - 1件: 298 💬
108 Pentoxifylline Pentoxifylline 1件: D00501 💬 - - 10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬
109 Perflubutane Perflubutane 1件: D05440 💬 - - 2件: 298, 300 💬
110 Pfd - - - - 2件: 51, 298 💬
111 Pioglitazone Pioglitazone 2件: D00945, D08378 💬 1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
112 Pl 00512/0150 - - - - 1件: 298 💬
113 Pregabalin Pregabalin 1件: D02716 💬 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 5件: 13, 36, 46, 70, 298 💬
114 Procedure: celiac block with triamcinolone and bupivicaine Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 298 💬
115 Procedure: endoscopic drainage of the main pancreatic duct - - - - 1件: 298 💬
116 Procedure: extracorporeal shock wave lithotripsy - - - - 1件: 298 💬
117 Procedure: no celiac block - - - - 1件: 298 💬
118 Prolastin - - - - 3件: 231, 298, 299 💬
119 Prolastin-c - - - - 2件: 231, 298 💬
120 Proton pump inhibitor (ppi) - - - - 1件: 298 💬
121 Radiation: uv-filtered light. - - - - 1件: 298 💬
122 Radiation: uvb - - - - 1件: 298 💬
123 Recombinant microbial lipase - - - - 1件: 298 💬
124 Recombinant microbial lipase slv339 - - - - 1件: 298 💬
125 Regn475/sar164877 - - - - 1件: 298 💬
126 Reparixin Reparixin 1件: D08984 💬 2件: CXCR1, CXCR2 💬 7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 2件: 298, 299 💬
127 Rg1068 (synthetic human secretin) Secretin human - - - 1件: 298 💬
128 Rvg 13760 - - - - 1件: 298 💬
129 S-ketamin - - - - 1件: 298 💬
130 Sa - - - - 5件:  6 , 30, 60, 118, 298 💬
131 Sa-001 - - - - 1件: 298 💬
132 Secretin Secretin human - - - 1件: 298 💬
133 Selenium Selenium - - - 3件: 13, 278, 298 💬
134 Simvastatin Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
135 Slv339 - - - - 1件: 298 💬
136 Somatuline - - - - 2件: 67, 298 💬
137 Somatuline autogel 90 mg - - - - 1件: 298 💬
138 Soy bread - - - - 1件: 298 💬
139 Synthetic human secretin Secretin human - - - 1件: 298 💬
140 Tanezumab Tanezumab 1件: D09387 💬 1件: NGF 💬 9件: Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 2件: 226, 298 💬
141 Tetrahydro-6,6,9-tri methyl-3-penthyl-6 h-dibenzo[ b,d ]pyran-1-ol - - - - 1件: 298 💬
142 Tetrahydrocannabinol Dronabinol 1件: D00306 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 3件:  8 , 13, 298 💬
143 Thalidomide Thalidomide 1件: D00754 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 20件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬
144 Tocopherol Tocopherol 1件: D02332 💬 - - 5件: 13, 49, 206, 257, 298 💬
145 Triamcinolone Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
146 Tyr - - - - 2件: 75, 298 💬
147 Viokase 16 - - - - 1件: 298 💬
148 Viokase 16 (pancrelipase) + nexium Pancrelipase 1件: D05349 💬 - - 1件: 298 💬
149 Viokase® 16 - - - - 1件: 298 💬
150 Vitamin d Vitamin D - - - 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬
151 Vitamin d 100ug Vitamin D - - - 1件: 298 💬
152 Vitamin d 10ug Vitamin D - - - 1件: 298 💬
153 Yarrowia lipolytica lipase - - - - 1件: 298 💬
154 Zenpep - - - - 2件: 298, 299 💬
155 Zentase - - - - 1件: 298 💬

先頭へ